| Metric | Q2'26 | Q3'26 | Change |
|---|---|---|---|
| Revenue | $460M, +24% YoY | $526M, +33-36% YoY | +14% QoQ acceleration |
| Net Income | $91M | $120M | +32% QoQ |
| Net margin | 20% | 23% | +300bps |
| EPS diluted | $0.79 | $1.05 | +33% |
| Gross profit | $138M, 30% GM | $179M record | +30% QoQ |
| Operating profit | $90M | $127M | +41% QoQ |
| SiPho quarterly revenue | Q2 run rate $680M annualized | $240M actual Q3 revenue | Run-rate framing replaced by quarterly actual |
| SiPho Q4 run-rate target | Targeting $1.0B | Expected to exceed $1.1B | Raised, but still a target not an actual |
| CapEx paid (of $920M program) | ~50% paid | ~65% paid | On track, +15pts |
| Long-term financial model (revenue/net profit) | $3.6B / $1.2B (33% margin) | $3.6B / $1.2B (33% margin), unchanged | Frozen for 2 straight quarters despite beat-and-raise |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.